NXTC FY 2019 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$35M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M

Gross Profit

-$28M-439.1% margin

Operating Income

-$37M-590.5% margin

Net Income

-$34M-531.5% margin

EPS (Diluted)

$-25.79

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$39M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$356M

Total Liabilities

$35M

Stockholders' Equity

$321M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$0	—
Gross Profit	-$28M	-$2M	-1561.8%
Operating Income	-$37M	-$23M	-61.6%
Net Income	-$34M	-$23M	-48.0%